| 2025 |
Cryo-EM structures of human HCAR1 in complex with Gi1 protein were solved at 3.16 Å (with agonist CHBA) and 3.36 Å (apo form), revealing the ligand recognition pocket, receptor activation mechanism, and G protein coupling interface. Mutagenesis and cellular functional assays identified key residues determining ligand selectivity between HCAR1 and HCAR2. The orthosteric pocket of HCAR1 is smaller and more compact than HCAR2, explaining subtype selectivity. |
Cryo-EM structure determination + site-directed mutagenesis + cellular cAMP functional assays |
PLoS biology |
High |
40233099
|
| 2026 |
Cryo-EM structures of HCAR1-Gαi1 complex in apo, L-lactate-bound, and CHBA-bound states revealed that HCAR1 has a compact binding pocket stabilized by three unique disulfide bonds. L-lactate shows flexible binding with weak intermolecular interactions (requiring millimolar concentrations), while CHBA binds more stably via its chlorinated benzene ring. Self-activation of HCAR1 is driven by conformational rearrangements in extracellular loop 2, with Phe168(ECL2) acting as a key intrinsic agonist. |
Cryo-EM structure determination + structural comparison with HCAR2 + mutagenesis |
Science signaling |
High |
41493973
|
| 2025 |
Using ebBRET assays, HCAR1 was shown to preferentially activate Gαi/o and Gαs pathways without recruiting β-arrestins, revealing a distinct signaling profile. AZ7136 was identified as a potent HCAR1 agonist, AZ2114 as a partial agonist, and GPR81 agonist 1 as an ago-positive allosteric modulator of HCAR1. |
Enhanced bystander bioluminescence resonance energy transfer (ebBRET) assays for G protein activation and β-arrestin recruitment |
British journal of pharmacology |
High |
41435849
|
| 2019 |
HCAR1 activation in primary cortical neurons causes downmodulation of neuronal network activity through presynaptic mechanisms (decreased miniature EPSC frequency, increased paired-pulse ratio) and reduced neuronal excitability. HCAR1 signals through Gαi-protein, engaging the adenylyl cyclase-cAMP-PKA axis. HCAR1 functionally interacts with adenosine A1, GABAB, and α2A-adrenergic receptors through both Gαi and Gβγ subunits. HCAR1 KO neurons showed increased basal activity compared to WT. |
Whole-cell patch clamp, fast calcium imaging, pharmacological inhibitors, comparison of WT vs. HCAR1 KO neurons |
The Journal of neuroscience |
High |
30926749
|
| 2017 |
HCAR1 is highly enriched in pial fibroblast-like cells lining brain vessels and in pericyte-like cells along intracerebral microvessels. Activation of HCAR1 by lactate (via exercise or subcutaneous L-lactate injection) increases brain VEGFA protein and capillary density in wild-type mice but not in HCAR1 KO mice, demonstrating HCAR1-dependent cerebral angiogenesis. |
Immunohistochemistry, HCAR1 KO mouse model, exercise and subcutaneous L-lactate injection, capillary density measurement, VEGFA protein quantification |
Nature communications |
High |
28534495
|
| 2022 |
Activation of HCAR1 with a non-metabolized agonist decreased spontaneous neuronal Ca2+ spiking frequency and excitatory post-synaptic currents (sEPSCs) in human brain slices from epileptic patients. In mouse brain, HCAR1 is expressed in dentate gyrus mossy cells; its activation reduces excitability, sEPSCs, and miniature EPSC frequency in granule cells. |
Pharmacological HCAR1 activation in human brain slices (patch clamp, Ca2+ imaging), fluorescent reporter mouse line, in situ hybridization, whole-cell patch clamp in mouse and rat slices |
Journal of cerebral blood flow and metabolism |
High |
35240875
|
| 2019 |
Lactate reduces epileptiform activity in rat subicular neurons through HCA1/GIRK channel activation. HCA1 activation hyperpolarizes subicular neurons and reduces spike frequency via Gβγ subunit and GIRK (G protein-coupled inwardly rectifying potassium) channel activation. Intracellular cAMP is also involved. |
Patch clamp electrophysiology on rat hippocampal slices, pharmacological HCA1 agonist, GIRK channel blocker (tertiapin-Q), immunohistochemistry |
Epilepsia |
High |
31755997
|
| 2016 |
GPR81/HCAR1 is expressed in uterine myometrium and its expression increases during gestation, peaking near labor. Lactate acting via GPR81 decreases IL-1β-induced transcription of proinflammatory genes (Il1b, Il6, Ccl2, Pghs2) in myometrial smooth muscle cells and ex vivo uteri. These suppressive effects were absent in GPR81 KO mice or shRNA-GPR81-treated cells. GPR81 silencing augmented proinflammatory gene expression and preterm birth. |
Primary myometrial smooth muscle cell culture, ex vivo uterus, shRNA knockdown, GPR81 KO mice, endotoxin-induced preterm birth model |
American journal of obstetrics and gynecology |
High |
27615440
|
| 2020 |
Lactate acts via HCAR1 (HCA1) to induce neurogenesis in the ventricular-subventricular zone (V-SVZ). Exercise or L-lactate injection increased proliferating cells (Ki-67+) and immature neurons (doublecortin+) in the V-SVZ of wild-type but not HCA1 KO mice. In contrast, subgranular zone neurogenesis was induced by exercise in both genotypes but was unaffected by lactate treatment alone. |
Wild-type vs. HCA1 KO mice, exercise protocol and subcutaneous L-lactate injection, Ki-67 and doublecortin immunolabeling |
Acta physiologica |
High |
33244894
|
| 2022 |
HCAR1 KO mice showed reduced tissue regeneration, impaired proliferation of neural progenitor cells and glial cells, and impaired microglial activation after neonatal hypoxia-ischemia. Transcriptome analysis revealed approximately 7300 genes responding to HI in WT subventricular zone versus only ~750 in HCAR1 KO, with cell cycle and innate immunity pathways dysregulated in KO mice. |
HCAR1 KO mouse model, neonatal HI model, transcriptome analysis, immunolabeling for cell proliferation and microglial markers |
eLife |
High |
35942676
|
| 2020 |
HCAR1-mediated lactate uptake via MCT1 promotes ATP production in hepatocellular carcinoma (HCC) cells, deactivating AMPK, which upregulates SREBP1 and downstream SCD1 to enhance production of anti-ferroptotic monounsaturated fatty acids. Blocking lactate uptake via HCAR1/MCT1 inhibition promotes ferroptosis by activating AMPK to downregulate SCD1 and amplifying ACSL4-dependent ferroptotic susceptibility. |
In vitro HCC cell assays, HCAR1/MCT1 inhibition, AMPK activity assays, SREBP1/SCD1 expression analysis, in vivo tumor models |
Cell reports |
High |
33296645
|
| 2021 |
HCAR1/GPR81 is expressed in retinal ganglion cells (RGCs) during visual system development. Activation of GPR81 with L-lactate or 3,5-DHBA alters growth cone morphology (increasing size and filopodia number) and promotes RGC axon growth in retinal explants. These effects were mediated by protein kinases A and C and were absent in gpr81 KO explants. Living gpr81 KO mice showed decreased ipsilateral RGC projections to the dorsal lateral geniculate nucleus. |
Immunohistochemistry, retinal explant cultures, pharmacological PKA/PKC inhibitors, gpr81 KO mice, in vivo projection analysis |
Cells |
High |
34208876
|
| 2017 |
HCAR1 activation by DHBA upregulates BRCA1 and NBS1 expression in HeLa cells, with increased nuclear accumulation of BRCA1, nibrin, and DNA-PKcs. This translates into enhanced DNA repair rate after doxorubicin treatment. HCAR1 silencing decreased BRCA1 and NBS1 mRNA/protein and reduced DNA repair efficiency. The DHBA-driven BRCA1 upregulation and enhanced DNA repair were abrogated by PKC inhibitor Gö6983. |
HCAR1 agonist (DHBA) treatment, HCAR1 siRNA silencing, immunocytochemistry, γ-H2AX and comet assays, PKC inhibitor |
DNA repair |
Medium |
28258841
|
| 2017 |
HCAR1 activation by L-lactate, D-lactate, or DHBA upregulates ABCB1 (P-glycoprotein) transporter mRNA and protein in HeLa cervical cancer cells, reducing doxorubicin accumulation. HCAR1 silencing decreased ABCB1 expression by 80% (mRNA) and 40% (protein) and increased accumulation of ABCB1 substrates. DHBA-stimulated ABCB1 upregulation was suppressed by PKC pathway inhibition. |
HCAR1 agonists, siRNA silencing, qPCR, western blot, doxorubicin accumulation assay, PKC inhibitor, cell viability and annexin V assays |
Journal of physiology and pharmacology |
Medium |
29151072
|
| 2023 |
Lactate activates HCAR1 to upregulate NOX4 expression in chondrocytes via the PI3K/Akt signaling pathway, increasing NADPH oxidase-dependent ROS generation and contributing to osteoarthritis cartilage damage. Lactate also acts metabolically by shunting glucose to the pentose phosphate pathway to increase NADPH levels. |
Human chondrocyte cultures, HCAR1 receptor activation, PI3K/Akt pathway analysis, NOX4 inhibitor GLX351322, ROS measurement, in vivo intra-articular lactate injection in rat OA model |
Redox biology |
Medium |
37688977
|
| 2012 |
Naturally occurring missense variants of HCA1 (A110V, S172L, D253H) show reduced basal activity in luciferase reporter assays; S172L shows decreased potency for L-lactate and both S172L and D253H show impaired cell surface expression. Knockdown of HCA1 with siRNA in differentiating OP9 adipocytes increased lipid accumulation, demonstrating HCA1's role in regulating lipid homeostasis in adipocytes. |
Transient expression in HEK293 cells, luciferase reporter gene assays, siRNA knockdown in OP9 adipocytes, Nile Red staining and TLC for lipid quantification |
Journal of lipid research |
Medium |
23268337
|
| 2024 |
HCAR1 activation (HCAR1-dependent) by L-lactate administered 24 h and 48 h after experimental stroke reduced lesion volume and enhanced angiogenesis in wild-type mice but not in HCAR1 KO mice. HCAR1 KO mice had smaller lesion volumes than WT controls regardless of L-lactate treatment, indicating a multifactorial role of HCAR1 in stroke outcome. |
Permanent distal MCA occlusion in WT vs. HCAR1 KO mice, IP L-lactate injection, Nissl-stained lesion volume measurement, immunolabeling for capillary density and neurogenesis |
International journal of molecular sciences |
Medium |
38279234
|
| 2022 |
HCAR1 activation did not provide neuroprotection in wild-type mice subjected to MCAO; HCAR1 KO mice actually showed smaller ischemic lesions and better behavioral outcomes than wild-type mice, indicating that lactate-mediated protection from ischemia is not achieved through HCAR1 activation (negative finding for HCAR1-mediated neuroprotection in this model). |
HCAR1 KO and WT mice subjected to transient MCAO, HCAR1 agonist administration at reperfusion, lesion volume measurement, behavioral outcome assessment |
Metabolites |
Medium |
35629969
|
| 2022 |
HCAR1-mediated L-lactate signaling suppresses microglial phagocytosis in a receptor-dependent but MCT1-independent manner. L-lactate reduces microglial phagocytic capacity through HCAR1. |
Microglial phagocytosis assay, pharmacological HCAR1 activation, comparison with MCT1-dependent effects |
Neuromolecular medicine |
Medium |
35411485
|
| 2020 |
HCA1 is localized in fibroblasts of the choroid plexus (CP), tela choroidea, and neuroepithelial ventricular lining of the dorsal third ventricle, as well as in ependymal cells of the tela choroidea and ventricle lining. Co-labeling identified specific cell types using mRFP-HCA1 reporter mice. |
mRFP-HCA1 reporter mouse line, fluorescence microscopy, co-labeling with cell-type markers |
International journal of molecular sciences |
Medium |
32899645
|
| 2025 |
HCAR1 activation by lactate in colorectal tumor cells induces expression of chemokines CCL2 and CCL7, leading to recruitment of immunosuppressive CCR2+ PMN-MDSCs to the tumor microenvironment. Ablation of Hcar1 decreased tumor-infiltrating CCR2+ PMN-MDSCs, enhanced CD8+ T cell activation, and reduced tumor burden. Reserpine suppressed lactate-mediated HCAR1 activation and impaired PMN-MDSC recruitment. |
Hcar1 KO mouse colorectal tumor model, chemokine expression analysis, flow cytometry for immune cell profiling, in vivo tumor burden measurement, pharmacological HCAR1 inhibition with reserpine |
Nature immunology |
High |
39905201
|
| 2025 |
Lactate-activated HCAR1 promotes osteosarcoma progression by recruiting β-Arrestin2 to facilitate PP2A interaction with phosphorylated STAT1/2, resulting in STAT1/2 dephosphorylation and suppression of anti-oncogenic transcription. PP2A inhibitor Endothall abolished HCAR1-mediated STAT1/2 dephosphorylation and inhibited cancer cell proliferation. |
Co-immunoprecipitation, western blot for phospho-STAT1/2, PP2A inhibitor treatment, gain/loss-of-function experiments in osteosarcoma cells |
Advanced science |
Medium |
40956299
|
| 2024 |
HCAR1-deficient mice exhibit lowered seizure thresholds, increased seizure severity and duration. Absence of HCAR1 led to uncontrolled inter-ictal activity in acute hippocampal slices. Lactate dehydrogenase A inhibition recapitulated the HCAR1 KO phenotype, indicating HCAR1 activation is coupled to glycolytic output. However, synthetic HCAR1 agonist administration in vivo did not modulate seizures, likely due to endogenous lactate competition. |
HCAR1 KO mice, in vivo EEG seizure analysis, acute hippocampal slice electrophysiology, LDHa inhibitor treatment, time-frequency analysis |
iScience |
Medium |
38655197
|
| 2026 |
HCAR1 HCAR1 KO mice showed reduced axonal area in cortex and corpus callosum predominantly in unmyelinated axons, without effect on myelin area. In an organotypic brain slice model of neonatal hypoglycemia, lactate protected both axonal and myelin development partially via HCAR1. Live imaging indicated that cellular lactate uptake is influenced by HCAR1. |
HCAR1 KO mice, particle and colocalization analysis of axon/myelin markers, organotypic brain slice hypoglycemia model, live pH-sensitive dye imaging |
eNeuro |
Medium |
40345852
|
| 2024 |
HCAR1 is exclusively expressed in RPE cells within the subretina. HCAR1-deficient mice exhibit substantially thinner choroidal vasculature during development, with impaired lactate-induced angiogenic effects. HCAR1 deficiency elevates endoplasmic reticulum stress and eIF2α phosphorylation, reduces global protein translation and choroidal cell proliferation. Inhibition of the integrated stress response (ISR) rescued protein translation and choroidal thinning. |
HCAR1 KO mouse model, immunohistochemistry, choroidal vascular measurement, ER stress markers, eIF2α phosphorylation assay, ISR inhibitor rescue experiment |
The American journal of pathology |
Medium |
39332673
|
| 2025 |
In hyperglycemic podocytes, GPR81/HCAR1 expression decreases and the cAMP/PKA signaling pathway is downregulated, leading to reduced ATGL and Perilipin-1 expression, lipid droplet accumulation, and lipolysis inhibition. These changes associate with increased albumin permeability and actin cytoskeleton rearrangement. ATGL inhibition phenocopied GPR81 downregulation effects, identifying GPR81 as a lipid-sensing regulator of podocyte lipolysis and cytoskeletal integrity. |
Primary podocyte cultures under hyperglycemia, cAMP/PKA pathway assay, ATGL and Perilipin-1 expression, lipid droplet quantification, glycerol/fatty acid measurement, albumin permeability assay |
Journal of cellular physiology |
Medium |
39962919
|
| 2026 |
Astrocytic HCAR1 is highly expressed in hypothalamic astrocytes. L-lactate activation of astrocytic HCAR1 elicits cytosolic Ca2+ increases and stimulates glutamate release (both abolished by HCAR1 siRNA silencing). L-lactate and 3Cl-HBA increased connexin hemichannel activity, and hemichannel inhibition reduced glutamate release. Focal intracellular glucose delivery to a single tanycyte triggered rapid Ca2+ elevations in neighboring astrocytes. Astrocytic HCAR1 activation enhanced NMDA receptor-dependent slow inward currents and excitability in POMC neurons; this was abolished by astrocytic HCAR1 silencing. |
siRNA silencing of astrocytic HCAR1, Ca2+ imaging, glutamate release assay, connexin hemichannel inhibition, patch clamp on POMC neurons in acute hypothalamic slices, single tanycyte glucose microinjection |
Proceedings of the National Academy of Sciences of the United States of America |
High |
41945430
|
| 2026 |
HCAR1 activation by apical (but not basal) L- and D-lactate enhances tight junctions and reduces permeability in differentiated Caco2 colonic epithelial cells via Gαi signaling. Apical lactate also rescued LPS-induced barrier dysfunction. The effect is consistent with HCAR1's apical membrane localization. |
Caco2 cell differentiation, apical vs. basal lactate treatment, Gαi inhibitor (pertussis toxin), tight junction and permeability assays, LPS barrier disruption model |
Biomedicine & pharmacotherapy |
Medium |
41616468
|
| 2026 |
HCAR1 expression on neonatal hippocampal neurons was confirmed by qRT-PCR. Lactate decreased sEPSC amplitude and frequency in wild-type but not HCAR1 KO hippocampal neurons. HCAR1 KO mice subjected to neonatal hypoxia-ischemia had significantly higher seizure burden and behavioral seizure scores than wild-type, and HCAR1 expression increased 24h post-HI then dropped below baseline by 48h. |
qRT-PCR, patch clamp electrophysiology in HCAR1 KO vs. WT hippocampal neurons, neonatal HI model with EEG monitoring |
Epilepsia |
Medium |
41744475
|